Leading Venture Capitalists to Discuss Biotech, Information Technology & Investing

Apr 18, 2001, 01:00 ET from Technology Vision Group LLC

    MONTEREY Bay, Calif., April 18 /PRNewswire/ -- Technology Vision Group LLC
 has announced today that they have confirmed 12 prominent venture capitalist
 to lead Discussion Groups at the 3rd Annual C21 Ventures Conference,
 May 22 - 23, 2001 at Seascape Resort.  The annual retreat will focus on the
 convergence of biotechnology and information technology (BT - IT), offering
 12 interactive discussion groups for CEOs from the BT-IT communities and
 venture capitalists from leading venture capital firms and panelists with
 expert insights.
     C21 Ventures will offer this novel concept of bringing together members of
 the investment and scientific communities to discuss and explore insights for
 the future of the biotechnology and information technology industries. The
 theme from last year's conference will be carried over into this year's
 conference by allowing the biotech and IT industries to hear the investors'
 view on investing in these two fields, which are converging to advance the
 field of healthcare.  Nola Masterson, President and CEO of Science Futures,
 Inc., remarked about last year's conference, "This conference provided
 futurist views which allowed me to put together an investment strategy for the
 long term -- then, it showcased the future companies in which to invest."
     Discussion Groups with expert panelists will address topics such as public
 and private investing in biotechnology and healthcare in the past and future,
 applications for new technologies, and the convergence of BT -- IT.  Leaders
 of the Discussion Groups include:  Brian Atwood, Versant Ventures;
 John Brooks III, Prism Venture Partners; Tom Daniel, Schroder Ventures Life
 Sciences; Dennis Dougherty, Intersouth Partners; Rodney Ferguson,
 J.P. Morgan Partners, LLC; John Freund, Skyline Ventures; Vera Kallmeyer,
 Earlybird Venture Capital; Vijay Lathi, Sprout Group; Eric Linsley, A.M.Pappas
 & Associates, LLC; Michael Lytton, Esq., Oxford Bioscience Partners; Bob More,
 Domain Associates; and Bryan Roberts, Venrock Associates.
     Attending delegates will have the opportunity to reserve a seat for
 Discussion Groups prior to the conference via the website for C21 Ventures.
 Complete and updated conference information, including the discussion group
 topics and panelists, and a conference program are available online at
 www.techvision.com.  Conference registration brochures are also downloadable
 online.
     For specific questions regarding the conference, contact Nancy Connelly,
 Conference Director, Technology Vision Group LLC at neconnelly@techvision.com
 or phone, 831-464-7100.
 
 

SOURCE Technology Vision Group LLC
    MONTEREY Bay, Calif., April 18 /PRNewswire/ -- Technology Vision Group LLC
 has announced today that they have confirmed 12 prominent venture capitalist
 to lead Discussion Groups at the 3rd Annual C21 Ventures Conference,
 May 22 - 23, 2001 at Seascape Resort.  The annual retreat will focus on the
 convergence of biotechnology and information technology (BT - IT), offering
 12 interactive discussion groups for CEOs from the BT-IT communities and
 venture capitalists from leading venture capital firms and panelists with
 expert insights.
     C21 Ventures will offer this novel concept of bringing together members of
 the investment and scientific communities to discuss and explore insights for
 the future of the biotechnology and information technology industries. The
 theme from last year's conference will be carried over into this year's
 conference by allowing the biotech and IT industries to hear the investors'
 view on investing in these two fields, which are converging to advance the
 field of healthcare.  Nola Masterson, President and CEO of Science Futures,
 Inc., remarked about last year's conference, "This conference provided
 futurist views which allowed me to put together an investment strategy for the
 long term -- then, it showcased the future companies in which to invest."
     Discussion Groups with expert panelists will address topics such as public
 and private investing in biotechnology and healthcare in the past and future,
 applications for new technologies, and the convergence of BT -- IT.  Leaders
 of the Discussion Groups include:  Brian Atwood, Versant Ventures;
 John Brooks III, Prism Venture Partners; Tom Daniel, Schroder Ventures Life
 Sciences; Dennis Dougherty, Intersouth Partners; Rodney Ferguson,
 J.P. Morgan Partners, LLC; John Freund, Skyline Ventures; Vera Kallmeyer,
 Earlybird Venture Capital; Vijay Lathi, Sprout Group; Eric Linsley, A.M.Pappas
 & Associates, LLC; Michael Lytton, Esq., Oxford Bioscience Partners; Bob More,
 Domain Associates; and Bryan Roberts, Venrock Associates.
     Attending delegates will have the opportunity to reserve a seat for
 Discussion Groups prior to the conference via the website for C21 Ventures.
 Complete and updated conference information, including the discussion group
 topics and panelists, and a conference program are available online at
 www.techvision.com.  Conference registration brochures are also downloadable
 online.
     For specific questions regarding the conference, contact Nancy Connelly,
 Conference Director, Technology Vision Group LLC at neconnelly@techvision.com
 or phone, 831-464-7100.
 
 SOURCE  Technology Vision Group LLC